Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

0.5340

-0.0045 (-0.84%)

At close: May 13, 2025, 4:00 PM

0.5339

-0.0001 (-0.02%)

Pre-market: May 14, 2025, 8:20 AM EDT

Oncolytics Biotech Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	13.34	16.08	11.49	13.32	12.51	Upgrade
Research & Development	21.65	17.71	15.43	12.92	12.95	Upgrade
Operating Expenses	34.98	33.79	26.92	26.24	25.46	Upgrade
Operating Income	-34.98	-33.79	-26.92	-26.24	-25.46	Upgrade
Interest & Investment Income	1.2	1.33	0.53	0.1	0.12	Upgrade
Currency Exchange Gain (Loss)	0.96	-0.48	1.67	-0.14	-0.66	Upgrade
Other Non Operating Income (Expenses)	1.24	5.29	-0.02	0.02	3.49	Upgrade
EBT Excluding Unusual Items	-31.58	-27.66	-24.75	-26.26	-22.51	Upgrade
Pretax Income	-31.58	-27.66	-24.75	-26.26	-22.51	Upgrade
Income Tax Expense	0.13	0.1	0.08	0.05	-	Upgrade
Net Income	-31.71	-27.75	-24.84	-26.3	-22.51	Upgrade
Net Income to Common	-31.71	-27.75	-24.84	-26.3	-22.51	Upgrade
Shares Outstanding (Basic)	76	68	58	54	40	Upgrade
Shares Outstanding (Diluted)	76	68	58	54	40	Upgrade
Shares Change (YoY)	13.10%	16.53%	8.44%	32.66%	82.22%	Upgrade
EPS (Basic)	-0.41	-0.41	-0.43	-0.49	-0.56	Upgrade
EPS (Diluted)	-0.41	-0.41	-0.43	-0.49	-0.56	Upgrade
Free Cash Flow	-27.21	-28.46	-23.41	-22.72	-22.1	Upgrade
Free Cash Flow Per Share	-0.36	-0.42	-0.40	-0.42	-0.55	Upgrade
EBITDA	-34.88	-33.71	-26.83	-26.11	-25.37	Upgrade
D&A For EBITDA	0.1	0.08	0.09	0.13	0.09	Upgrade
EBIT	-34.98	-33.79	-26.92	-26.24	-25.46	Upgrade

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q